Researchers discover that bone marrow cancer cells diversify drastically when exiting the bone marrow, which also affects the ...

Throughout my experience with multiple myeloma, I was humbled by the unexpected support and kindness shown to me.

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...

The team tackled a critical challenge in treating multiple myeloma—a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients.

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...

The team tackled a critical challenge in treating multiple myeloma-a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients ...

Black Americans have double the risk of developing multiple myeloma compared to white Americans and are diagnosed at younger ages.

The team tackled a critical challenge in treating multiple myeloma -- a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients ...

has developed a new biomaterial with high potential in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a promising approach to bone ...